Zoetis Inc (NYSE:ZTS) – Stock analysts at William Blair boosted their Q1 2018 earnings estimates for shares of Zoetis in a report released on Thursday. William Blair analyst J. Kreger now forecasts that the company will post earnings of $0.69 per share for the quarter, up from their previous forecast of $0.62. William Blair also issued estimates for Zoetis’ Q2 2018 earnings at $0.72 EPS, Q3 2018 earnings at $0.79 EPS, Q4 2018 earnings at $0.79 EPS, FY2018 earnings at $3.00 EPS, FY2019 earnings at $3.31 EPS and FY2021 earnings at $4.01 EPS.
Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company’s revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the company earned $0.52 earnings per share.
Other equities analysts have also recently issued research reports about the stock. Cantor Fitzgerald set a $85.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research note on Thursday. BidaskClub cut shares of Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 20th. BMO Capital Markets boosted their price objective on shares of Zoetis from $65.00 to $70.00 and gave the company a “market perform” rating in a research note on Friday, November 3rd. Zacks Investment Research cut shares of Zoetis from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $65.00 price objective on shares of Zoetis in a research note on Tuesday, October 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $71.28.
Zoetis (ZTS) opened at $75.39 on Friday. The company has a market cap of $36,740.00, a P/E ratio of 39.68, a P/E/G ratio of 1.88 and a beta of 1.06. Zoetis has a 12 month low of $52.00 and a 12 month high of $75.69. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.
A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. lifted its position in Zoetis by 3.9% during the second quarter. BlackRock Inc. now owns 37,495,299 shares of the company’s stock valued at $2,338,957,000 after purchasing an additional 1,412,829 shares during the last quarter. Vanguard Group Inc. lifted its position in Zoetis by 2.8% during the second quarter. Vanguard Group Inc. now owns 33,654,686 shares of the company’s stock valued at $2,099,379,000 after purchasing an additional 910,265 shares during the last quarter. Janus Henderson Group PLC lifted its position in Zoetis by 1.5% during the third quarter. Janus Henderson Group PLC now owns 5,893,853 shares of the company’s stock valued at $375,792,000 after purchasing an additional 84,767 shares during the last quarter. Northern Trust Corp lifted its position in Zoetis by 1.2% during the second quarter. Northern Trust Corp now owns 5,533,313 shares of the company’s stock valued at $345,168,000 after purchasing an additional 63,849 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in Zoetis by 1.5% during the third quarter. Legal & General Group Plc now owns 2,400,106 shares of the company’s stock valued at $153,025,000 after purchasing an additional 34,747 shares during the last quarter. Institutional investors and hedge funds own 93.19% of the company’s stock.
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, January 19th will be given a dividend of $0.126 per share. The ex-dividend date of this dividend is Thursday, January 18th. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 0.67%. Zoetis’s payout ratio is presently 22.11%.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.